The structure of any deal with big pharma is going to be very interesting.
- Maybe a sell off or partial sell off of the Derma / Permetrex side of the business to fund the antibiotic / antimicrobial side.
- Maybe keeping control of the Permetrex license and a separate sell off of Derma products to different companies. Possibly keeping a partial ownership or complete sale.
- Maybe keeping a percentage of everything and only partnering with a big pharma to a certain percentage of the business.
Anyway you spin this there is plenty of options. As someone who has commitment issues... I like me some options.
IMO we'll see some very creative deal making in the near (within 6 months) future. DYoR.
BOT - Anything but charting, page-94
-
- There are more pages in this discussion • 10,584 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 297011 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 12027 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |